Seeking Alpha
Value, growth, long-term horizon, medium-term horizon
Profile| Send Message| ()  

In the search for companies that have outperformed in a persistent way, we ran a screen on stocks from the healthcare sector for those that have seen a persistence of days in which the stock beat the S&P 500 benchmark over the last month and little persistence in underperforming the S&P 500, i.e. long winning streaks and short losing streaks, as measured by a ratio of the longest winning streak to the longest losing streak.

We then screened these stocks for those that have also seen significant net insider buying over the last six months.

Although past performance is no guarantee of future results, winning streaks may indicate upward momentum and positive sentiment.

Interactive Chart: Press Play to compare changes in analyst ratings over the last two years for the stocks mentioned below. Analyst ratings sourced from Zacks Investment Research.



We also created a price-weighted index of the stocks mentioned below, and monitored the performance of the list relative to the S&P 500 index over the last month. To access a complete analysis of this list's recent performance, click here.

Click to enlarge


Do you think these stocks will continue winning? Use this list as a starting point for your own analysis.

List sorted by win streak/lose streak ratio.

1. Auxilium Pharmaceuticals Inc. (AUXL): Operates as a specialty biopharmaceutical company primarily in the United States. Market cap of $815.63M. The stock's longest winning streak over the last month was 10 days, while the longest losing streak was two days, or a win streak/lose streak ratio of 5. Net insider shares purchased over the last six months at 973.07K, which is 2.22% of the company's 43.92M share float. The stock is a short squeeze candidate, with a short float at 15.27% (equivalent to 7.92 days of average volume). The stock has lost 36.1% over the last year.

2. Neoprobe Corp. (NEOP): Engages in the development and commercialization of surgical and diagnostic oncology products that enhance patient treatment by meeting the critical decision making needs of physicians in the United States and internationally. Market cap of $319.14M. The stock's longest winning streak over the last month was nine days, while the longest losing streak was two days, or a win streak/lose streak ratio of 4.5. Net insider shares purchased over the last six months at 100.32K, which is 0.11% of the company's 87.79M share float. The stock is a short squeeze candidate, with a short float at 13.28% (equivalent to 8.43 days of average volume). The stock has had a couple of great days, gaining 17.01% over the last week.

3. Opko Health, Inc. (OPK): Engages in the discovery, development and commercialization of novel and proprietary technologies primarily in the United States, Chile and Mexico. Market cap of $1.20B. The stock's longest winning streak over the last month was four days, while the longest losing streak was one day, for a win streak/lose streak ratio of 4. Net insider shares purchased over the last six months at 6.85M, which is 5.03% of the company's 136.15M share float. The stock is a short squeeze candidate, with a short float at 9.47% (equivalent to 10.9 days of average volume). The stock has had a couple of great days, gaining 7.46% over the last week.

4. Regeneron Pharmaceuticals, Inc. (REGN): Develops and commercializes pharmaceutical products for the treatment of serious medical conditions in the United States. Market cap of $5.41B. The stock's longest winning streak over the last month was six days, while the longest losing streak was three days, or a win streak/lose streak ratio of 2. Net insider shares purchased over the last six months at 675.38K, which is 0.95% of the company's 71.17M share float. The stock is a short squeeze candidate, with a short float at 12.01% (equivalent to 8.45 days of average volume). The stock has had a good month, gaining 12.87%.

5. Seattle Genetics Inc. (SGEN): Focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Market cap of $2.0B. The stock's longest winning streak over the last month was five days, while the longest losing streak was three days, or a win streak/lose streak ratio of 1.67. Net insider shares purchased over the last six months at 1.48M, which is 1.30% of the company's 113.17M share float. The stock is a short squeeze candidate, with a short float at 21.81% (equivalent to 10.83 days of average volume). The stock has had a couple of great days, gaining 12.48% over the last week.

*Insider data and price data sourced from Yahoo! Finance, all other data sourced from Finviz.

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Source: 5 Healthcare Insider Picks With A Recent History Of Winning